[Use of NSAIDs in rheumatoid arthritis should be limited]

Mats Lindberg1

  • 1Akutcentret, Sygehus Sønderjylland, Egelund 10, 6200 Aabenraa, Denmark. mli@dadlnet.dk

Ugeskrift for Laeger
|April 16, 2013
PubMed

Insights

Non-steroidal anti-inflammatory drugs (NSAIDs) appear safe with methotrexate for rheumatoid arthritis, but aspirin may cause kidney and liver issues. Limiting NSAID use is recommended due to known side effects and safer alternatives.

Area of Science:

  • Pharmacology
  • Rheumatology
  • Drug Safety

Context:

  • Rheumatoid arthritis (RA) management often involves disease-modifying antirheumatic drugs (DMARDs) like methotrexate (MTX).
  • Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used for symptomatic relief in RA patients on MTX.
  • Evaluating drug interactions and safety profiles is crucial for optimizing RA treatment.

Purpose:

  • To assess the safety of concurrent use of NSAIDs, including aspirin, with methotrexate in rheumatoid arthritis patients.
  • To analyze evidence from published literature regarding potential adverse events associated with this drug combination.
  • To provide an evidence-based opinion on the appropriate use of NSAIDs in RA management.

Summary:

  • A Cochrane review of 17 publications found that concurrent anti-inflammatory doses of aspirin with methotrexate (MTX) were linked to renal and hepatic side effects.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) generally appeared safe when used concurrently with MTX.
  • Despite apparent safety with MTX, NSAIDs carry well-documented gastrointestinal, cardiovascular, and renal risks.

Impact:

  • Findings suggest a need for caution with aspirin use in MTX-treated RA patients, particularly regarding renal and hepatic function.
  • The study highlights the inherent risks of NSAIDs, advocating for judicious use in rheumatoid arthritis.
  • Recommends exploring safer therapeutic alternatives for symptom management in rheumatoid arthritis patients on methotrexate.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...